Recent investigations have focused on the intersection of GLP|GIP|glucagon receptor activator therapies and dopamine communication. While GCGR stimulators are increasingly employed for managing type 2 diabetes mellitus, their unexpected consequences on reinforcement circuits, specifically governed by DA networks, are receiving considerable inter… Read More